TW286320B - - Google Patents
Info
- Publication number
- TW286320B TW286320B TW082100486A TW82100486A TW286320B TW 286320 B TW286320 B TW 286320B TW 082100486 A TW082100486 A TW 082100486A TW 82100486 A TW82100486 A TW 82100486A TW 286320 B TW286320 B TW 286320B
- Authority
- TW
- Taiwan
- Prior art keywords
- fragments
- pct
- parathormone
- sec
- amino acid
- Prior art date
Links
- 239000012634 fragment Substances 0.000 abstract 5
- 102000003982 Parathyroid hormone Human genes 0.000 abstract 3
- 108090000445 Parathyroid hormone Proteins 0.000 abstract 3
- 239000000199 parathyroid hormone Substances 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000007791 liquid phase Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000007790 solid phase Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Veterinary Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4203040A DE4203040A1 (de) | 1992-02-04 | 1992-02-04 | Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW286320B true TW286320B (zh) | 1996-09-21 |
Family
ID=6450869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW082100486A TW286320B (zh) | 1992-02-04 | 1993-01-28 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5783558A (zh) |
| EP (1) | EP0625163B1 (zh) |
| JP (1) | JPH07507051A (zh) |
| KR (1) | KR950700326A (zh) |
| AT (1) | ATE171952T1 (zh) |
| AU (1) | AU3628093A (zh) |
| CA (1) | CA2126974A1 (zh) |
| DE (2) | DE4203040A1 (zh) |
| HU (1) | HUT69708A (zh) |
| IL (1) | IL104580A (zh) |
| MX (1) | MX9300586A (zh) |
| TW (1) | TW286320B (zh) |
| WO (1) | WO1993015109A2 (zh) |
| ZA (1) | ZA93727B (zh) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08503692A (ja) * | 1992-08-05 | 1996-04-23 | アール． ヒリカー，サンドラ | 上皮小体ホルモン断片及びアナログ |
| US6551618B2 (en) | 1994-03-15 | 2003-04-22 | University Of Birmingham | Compositions and methods for delivery of agents for neuronal regeneration and survival |
| DE19538687A1 (de) * | 1995-10-17 | 1997-04-24 | Boehringer Mannheim Gmbh | Stabile pharmazeutische Darreichungsformen enthaltend Parathormon |
| ES2302374T3 (es) | 1998-05-05 | 2008-07-01 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Compuesto selectivo de receptores pth2. |
| US6689566B1 (en) | 1999-01-14 | 2004-02-10 | Scantibodies Laboratory, Inc. | Methods, kits, and antibodies for detecting parathyroid hormone |
| US7820393B2 (en) * | 1999-01-14 | 2010-10-26 | Scantibodies Laboratory, Inc. | Methods, kits and antibodies for detecting parathyroid hormone |
| US20080108086A1 (en) * | 1999-06-02 | 2008-05-08 | Cantor Thomas L | Parathyroid hormone antagonists and uses thereof |
| WO2004028444A2 (en) * | 1999-06-02 | 2004-04-08 | Scantibodies Laboratory, Inc. | Parathyroid hormone antagonists and uses thereof |
| EP1531855A4 (en) | 2002-01-10 | 2009-07-22 | Osteotrophin Llc | TREATMENT OF BONE DISEASES WITH SKELETTAL ANABOLIKA |
| US20040067526A1 (en) * | 2002-10-03 | 2004-04-08 | Cantor Thomas L. | Methods for diagnosing and guiding treatment of bone turnover disease |
| KR100540659B1 (ko) * | 2003-07-02 | 2006-01-10 | 삼성전자주식회사 | 이미지 확대 인쇄 방법과 장치 및 컴퓨터 프로그램을저장하는 컴퓨터로 읽을 수 있는 기록 매체 |
| US7541140B2 (en) * | 2004-06-03 | 2009-06-02 | Scantibodies Laboratory, Inc. | Assessing risk for kidney stones using parathyroid hormone agonist and antagonist |
| JP2009515535A (ja) * | 2005-11-10 | 2009-04-16 | ボード オブ コントロール オブ ミシガン テクノロジカル ユニヴァーシティー | クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法 |
| EP2509996A1 (en) | 2009-12-07 | 2012-10-17 | Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| CN108066740A (zh) * | 2016-11-07 | 2018-05-25 | 亿菩升（上海）生物科技有限公司 | 牛骨肽在制备治疗和预防骨质疏松的药物和食物中的应用 |
| CN111057139B (zh) * | 2018-10-17 | 2023-12-22 | 南京华威医药科技集团有限公司 | 一种制备特立帕肽的新工艺 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4086196A (en) * | 1975-03-28 | 1978-04-25 | Armour Pharmaceutical Company | Parathyroid hormone |
| US4423037A (en) * | 1982-05-13 | 1983-12-27 | The General Hospital Corporation | Inhibitors of peptide hormone action |
| US4833125A (en) * | 1986-12-05 | 1989-05-23 | The General Hospital Corporation | Method of increasing bone mass |
| US5457092A (en) * | 1987-07-30 | 1995-10-10 | Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) | Methods of promoting bone growth in mammals comprising administration of modified parathyroid hormone |
| DE3725320A1 (de) * | 1987-07-30 | 1989-02-09 | Biotechnolog Forschung Gmbh | Expressionsvektoren und verfahren unter deren verwendung zur gewinnung von cro/ss-galaktosidase/pth-fusionsproteinen und von pth |
| DE3935738A1 (de) * | 1989-10-27 | 1991-05-08 | Forssmann Wolf Georg | Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff |
| JP2952951B2 (ja) * | 1990-04-12 | 1999-09-27 | 三菱化学株式会社 | ペプチド誘導体 |
| GB9020544D0 (en) * | 1990-09-20 | 1990-10-31 | Sandoz Ltd | Improvements in or relating to organic compounds |
| JPH0532696A (ja) * | 1990-09-28 | 1993-02-09 | Takeda Chem Ind Ltd | 副甲状腺ホルモン誘導体 |
| US5434246A (en) * | 1992-03-19 | 1995-07-18 | Takeda Chemical Industries, Ltd. | Parathyroid hormone derivatives |
| US5358934A (en) * | 1992-12-11 | 1994-10-25 | The United States Of America As Represented By The Secretary Of Agriculture | Materials and methods for control of pests |
-
1992
- 1992-02-04 DE DE4203040A patent/DE4203040A1/de not_active Ceased
-
1993
- 1993-01-28 TW TW082100486A patent/TW286320B/zh active
- 1993-02-01 IL IL10458093A patent/IL104580A/xx not_active IP Right Cessation
- 1993-02-03 ZA ZA93727A patent/ZA93727B/xx unknown
- 1993-02-03 MX MX9300586A patent/MX9300586A/es unknown
- 1993-02-04 US US08/256,363 patent/US5783558A/en not_active Expired - Fee Related
- 1993-02-04 EP EP93905233A patent/EP0625163B1/de not_active Expired - Lifetime
- 1993-02-04 AT AT93905233T patent/ATE171952T1/de not_active IP Right Cessation
- 1993-02-04 JP JP5512945A patent/JPH07507051A/ja active Pending
- 1993-02-04 CA CA002126974A patent/CA2126974A1/en not_active Abandoned
- 1993-02-04 WO PCT/EP1993/000259 patent/WO1993015109A2/de active IP Right Grant
- 1993-02-04 DE DE59309044T patent/DE59309044D1/de not_active Expired - Fee Related
- 1993-02-04 HU HU9402272A patent/HUT69708A/hu active IP Right Revival
- 1993-02-04 AU AU36280/93A patent/AU3628093A/en not_active Abandoned
-
1994
- 1994-08-04 KR KR1019940702726A patent/KR950700326A/ko active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| US5783558A (en) | 1998-07-21 |
| ZA93727B (en) | 1994-08-03 |
| WO1993015109A2 (de) | 1993-08-05 |
| MX9300586A (es) | 1993-08-01 |
| KR950700326A (ko) | 1995-01-16 |
| CA2126974A1 (en) | 1993-08-05 |
| AU3628093A (en) | 1993-09-01 |
| IL104580A0 (en) | 1993-06-10 |
| HU9402272D0 (en) | 1994-11-28 |
| EP0625163B1 (de) | 1998-10-07 |
| IL104580A (en) | 1997-01-10 |
| DE4203040A1 (de) | 1993-08-05 |
| ATE171952T1 (de) | 1998-10-15 |
| HUT69708A (en) | 1995-09-28 |
| JPH07507051A (ja) | 1995-08-03 |
| DE59309044D1 (de) | 1998-11-12 |
| WO1993015109A3 (de) | 1993-08-19 |
| EP0625163A1 (de) | 1994-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW286320B (zh) | ||
| AU4835396A (en) | Composition containing nucleic acids, preparation and use | |
| GB2364304A (en) | Novel tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them | |
| IL112112A0 (en) | Peptide derivatives and pharmaceutical compositions containing them | |
| WO1994012219A3 (en) | Modified insulin-like growth factors | |
| AU2624400A (en) | Monodisperse hexameric acylated insulin analog formulations | |
| IL79379A0 (en) | Carboxylic acid derivatives,process for the preparation thereof and pharmaceutical compositions containing them | |
| GR3036966T3 (en) | Stabilized pseudo-emulsions and their preparation process | |
| IL113178A (en) | 8alpha-3-hydroxyestra-1,3,5(11)tetraen-17-one( 9(11)-dehydro-8-isoestrone) its preparation and pharmaceutical composition containing it | |
| AU601280B2 (en) | Mixed crystals of insulin and insulin derivatives, a process for the preparation of these mixed crystals, pharmaceutical agents containing these mixed crystals, and the use thereof for the treatment of diabetes mellitus | |
| EP0286441A3 (en) | Novel cytotoxic protein | |
| IN172427B (zh) | ||
| IL94693A0 (en) | Dibenzo(1,5)dioxocin-5-one derivatives,their preparation and pharmaceutical compositions containing them | |
| EP0347932A3 (en) | Treatment of conditions requiring enhanced oxygen availability to mammalian tissues | |
| GR1002576B (el) | Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους. | |
| EP0373613A3 (en) | Pyridine-3-percarboxylic acid monopersulfate | |
| IL105454A0 (en) | Water-soluble retinoids,their preparation and pharmaceutical and cosmetic compositions containing them | |
| MX9600165A (es) | 3-alcoxicarbonil-tiadiazinonas, proceso para su preparacion y composiciones farmaceuticas que las contienen. | |
| HUT53096A (en) | Process for producing thienylacetic acid derivatives and pharmaceutical compositions comprising same |